Immunovant, Inc. (IMVT)
26.67
-0.82
(-2.98%)
USD |
NASDAQ |
Feb 10, 16:00
26.67
0.00 (0.00%)
After-Hours: 19:07
Immunovant Total Assets (Quarterly) : 1.052B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | -- |
| Revvity, Inc. | 12.17B |
| Viridian Therapeutics, Inc. | 577.14M |
| Plus Therapeutics, Inc. | 18.67M |
| Nutriband, Inc. | 8.419M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 66.26M |
| Shareholders Equity (Quarterly) | 986.14M |
| Current Ratio | 15.74 |
| Net Debt Paydown Yield | 0.00% |